Skip to content

The effect of special combination of protein-amino acids supplementation in prevention of postoperative sarcopenia in patients undergoing a type of bariatric surgery

The effect of special combination of protein-amino acids supplementation in prevention of postoperative sarcopenia in patients undergoing mini gastric bypass surgery: A double-blind clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260104068547N1
Enrollment
60
Registered
2026-05-01
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia. Sarcopenia (Age-related loss of skeletal muscle mass and strength)

Interventions

Intervention 1: Intervention group: Here’s the English translation of your provided text:Based on studies, a combination of whey protein, glutamine, beta-hydroxy-beta-methylbutyrate (HMB), creatine, a

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 55 years Body Mass Index (BMI) between 30 and 50 Patients with an ASA Score of PS1 or PS2 Receiving the same dietary regimen

Exclusion criteria

Exclusion criteria: Previous history of bariatric surgery Severe liver dysfunction (based on ultrasound findings or liver enzyme levels: Alanine aminotransferase (ALT) > 50 U/L, Aspartate aminotransferase (AST) > 50 U/L, Alkaline phosphatase (ALP) > 300 U/L) Any renal disease Allergy or intolerance to the supplement Any condition that prevents the patient from continuing the study Lack of willingness to continue participation Use of any new nutritional or pharmaceutical supplements that may interfere with the intervention Non-adherence to supplement intake for more than 20% of the intervention period Non-adherence to the dietary regimen for more than 20% of the intervention period

Design outcomes

Primary

MeasureTime frame
Skeletal muscle mass(Measuring the amount of muscle changes in the body). Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: Bioimpedance analysis(BIA device: inbody570).;Muscular strength (measurement of changes). Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: handgrip dynamometer.;Muscular function (measurement of changes). Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: In the 4 meter gait speed test, the time required to walk 4 meters is measured. In the 5 times sit to stand test (5STS), the time required to sit and stand up from a chair 5 times in succession. The time taken from the start of the first movement to the end of the last movement is recorded using a stopwatch.

Secondary

MeasureTime frame
Fat mass. Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: Bioimpedance analysis(BIA device: inbody570).;Physical activity. Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: IPAC questionnaire.;Weight loss. Timepoint: Pre-intervention, and 1, 3, and 6 months post-surgery. Method of measurement: Bioimpedance analysis(BIA device: inbody570).

Countries

Iran (Islamic Republic of)

Contacts

Public Contactprofessor Razieh Khalouifard

Tehran University of Medical Sciences

Shkhalooei1367@gmail.com+98 21 8895 5742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026